SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003302
Filing Date
2018-04-27
Accepted
2018-04-27 16:38:30
Documents
6
Period of Report
2018-06-28
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235462zdef14a.htm DEF 14A 332577
2 G251456.JPG g251456.jpg GRAPHIC 8929
3 G104549.JPG g104549.jpg GRAPHIC 4023
4 G249170.JPG g249170.jpg GRAPHIC 4912
5 G30942BGI001.GIF g30942bgi001.gif GRAPHIC 105829
6 G30942BGI002.GIF g30942bgi002.gif GRAPHIC 107977
  Complete submission text file 0001047469-18-003302.txt   653267
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37926 | Film No.: 18784629
SIC: 2834 Pharmaceutical Preparations